We next performed targeted sequencing of SLC6A9 in the cohort of 725 sporadic AIS patients and a cohort of 3,219 ethnicity-matched participants without AIS in Hong Kong. This evidence concerns the gene SLC6A9 and androgen insensitivity syndrome.